Severe respiratory adverse events associated with rituximab infusion

Pediatric Nephrology

Volumn 25, Issue 6, 2010, Pages 1193-

  Kamei, Koichi ^a   Ito, Shuichi ^a   Iijima, Kazumoto ^b  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ALLERGIC PNEUMONITIS; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSPASM; COUGHING; DRUG INFUSION; DYSPNEA; FATIGUE; FEVER; HIGH RISK PATIENT; HUMAN; INTERSTITIAL PNEUMONIA; LETTER; LUNG FIBROSIS; LUNG INFILTRATE; LUNG TOXICITY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RESPIRATORY DISTRESS; STEROID THERAPY; THORAX PAIN; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CHILD; HUMANS; IMMUNOLOGIC FACTORS; LUNG DISEASES; MIDDLE AGED; NEPHROTIC SYNDROME; YOUNG ADULT;

EID: 77951255987     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1408-2     Document Type: Letter

References (2)

1. MC Chaumais A Garnier F Chalard M Peuchmaur S Dauger E Jacqz-Agrain G Deschênes 2009 Fatal pulmonary fibrosis after rituximab administration Pediatr Nephrol 24 1753 1755 10.1007/s00467-009-1195-9 19396468
2. M Bitzan M Anselmo L Carpineta 2009 Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature Pediatr Pulmonol 44 922 934 10.1002/ppul.20864 19681063